388 related articles for article (PubMed ID: 34960236)
1. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.
Ghattas M; Dwivedi G; Lavertu M; Alameh MG
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960236
[TBL] [Abstract][Full Text] [Related]
2. Recent Development of Ruminant Vaccine Against Viral Diseases.
Choudhury SM; Ma X; Dang W; Li Y; Zheng H
Front Vet Sci; 2021; 8():697194. PubMed ID: 34805327
[TBL] [Abstract][Full Text] [Related]
3. Current progress in the development of prophylactic and therapeutic vaccines.
Li T; Qian C; Gu Y; Zhang J; Li S; Xia N
Sci China Life Sci; 2023 Apr; 66(4):679-710. PubMed ID: 36469218
[TBL] [Abstract][Full Text] [Related]
4. Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.
Rodrigues AF; Soares HR; Guerreiro MR; Alves PM; Coroadinha AS
Biotechnol J; 2015 Sep; 10(9):1329-44. PubMed ID: 26212697
[TBL] [Abstract][Full Text] [Related]
5. Perspective vaccines for emerging viral diseases in farm animals.
Allam AM; Elbayoumy MK; Ghazy AA
Clin Exp Vaccine Res; 2023 Jul; 12(3):179-192. PubMed ID: 37599803
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.
Gupta S; Pellett S
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755989
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Vaccine Technologies.
Francis MJ
Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):231-241. PubMed ID: 29217317
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from COVID-19 pandemic: Vaccine platform is a key player.
Hossaini Alhashemi S; Ahmadi F; Dehshahri A
Process Biochem; 2023 Jan; 124():269-279. PubMed ID: 36514356
[TBL] [Abstract][Full Text] [Related]
10. Vaccine process technology.
Josefsberg JO; Buckland B
Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
[TBL] [Abstract][Full Text] [Related]
11. An overview of progress from empirical to rational design in modern vaccine development, with an emphasis on computational tools and immunoinformatics approaches.
Soleymani S; Tavassoli A; Housaindokht MR
Comput Biol Med; 2022 Jan; 140():105057. PubMed ID: 34839187
[TBL] [Abstract][Full Text] [Related]
12. Vaccine development: Current trends and technologies.
Poria R; Kala D; Nagraik R; Dhir Y; Dhir S; Singh B; Kaushik NK; Noorani MS; Kaushal A; Gupta S
Life Sci; 2024 Jan; 336():122331. PubMed ID: 38070863
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in veterinary vaccinology.
Shams H
Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
[TBL] [Abstract][Full Text] [Related]
14. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
15. Modern biotechnological strategies for vaccine development in aquaculture - Prospects and challenges.
Jose Priya TA; Kappalli S
Vaccine; 2022 Sep; 40(41):5873-5881. PubMed ID: 36088192
[TBL] [Abstract][Full Text] [Related]
16. African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.
Zhu JJ
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146827
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches to Neisseria meningitidis vaccine design.
Christodoulides M; Heckels J
Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28369428
[TBL] [Abstract][Full Text] [Related]
18. The use of viral vectors in vaccine development.
Travieso T; Li J; Mahesh S; Mello JDFRE; Blasi M
NPJ Vaccines; 2022 Jul; 7(1):75. PubMed ID: 35787629
[TBL] [Abstract][Full Text] [Related]
19. Synthetic biology: impact on the design of innovative vaccines.
Kindsmüller K; Wagner R
Hum Vaccin; 2011 Jun; 7(6):658-62. PubMed ID: 21445007
[TBL] [Abstract][Full Text] [Related]
20. [New technologies for vaccine development].
Leclerc C
Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
